首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 曹海龙
2024
CA
Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis
Pharmacol Res, 10.1016/j.phrs.2024.107108
CA
Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis
Microbiome, 10.1186/s40168-023-01722-8
点击查看热心肠日报解读
2023
CA
Dietary flavonoids-microbiota crosstalk in intestinal inflammation and carcinogenesis
J NUTR BIOCHEM, 10.1016/j.jnutbio.2023.109494
CA
Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Front Immunol, 10.3389/fimmu.2023.1158200
2022
CA
Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
Nutrients, 10.3390/nu14194003
CA
Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
Front Immunol, 10.3389/fimmu.2022.974305
CA
Early life dietary emulsifier exposure predisposes the offspring to obesity through gut microbiota-FXR axis
FOOD RES INT, 10.1016/j.foodres.2022.111921
CA
Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis
Nutrients, 10.3390/nu14163383
CA
Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota
Pharmacol Res, 10.1016/j.phrs.2022.106291
点击查看热心肠日报解读
CA
Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation
Food Funct, 10.1039/d2fo00478j
CA
Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation
Food Funct, 10.1039/d2fo00478j
CA
Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation
Food Funct, 10.1039/d2fo00478j
CA
Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation
Food Funct, 10.1039/d2fo00478j
CA
Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation
Food Funct, 10.1039/d2fo00478j
CA
Bile acid-gut microbiota crosstalk in irritable bowel syndrome
Crit Rev Microbiol, 10.1080/1040841X.2022.2058353
点击查看热心肠日报解读
2021
CA
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1 α Pathway
OXID MED CELL LONGEV, 10.1155/2021/3328505
点击查看热心肠日报解读
CA
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1 α Pathway
OXID MED CELL LONGEV, 10.1155/2021/3328505
点击查看热心肠日报解读
CA
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1 α Pathway
OXID MED CELL LONGEV, 10.1155/2021/3328505
点击查看热心肠日报解读
CA
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1 α Pathway
OXID MED CELL LONGEV, 10.1155/2021/3328505
点击查看热心肠日报解读
CA
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1 α Pathway
OXID MED CELL LONGEV, 10.1155/2021/3328505
点击查看热心肠日报解读